OKYO Pharma Limited Receives Nasdaq Deficiency Notice

NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) ("OKYO" or the "Company"), an ophthalmology-focused bio-pharmaceutical...

Related Keywords

Garys Jacob ,Paul Spencer ,Nasdaq ,Pharma Limited Nasdaq ,Nasdaq Listing Qualifications Panel The ,Listing Qualifications Department ,Nasdaq Stock Market ,Nasdaq Capital Market ,Nasdaq Listing Rule ,Nasdaq Capital ,Market Value ,Compliance Date ,Compliance Period Rule ,Market Value Rule ,Nasdaq Listing Qualifications Panel ,Chief Executive ,Nasdaq Okyo ,Okyo Pharma Ltd ,